In Vitro Antiviral Susceptibilities of Isolates from Cytomegalovirus Retinitis Patients Receiving First- or Second-Line Cidofovir Therapy: Relationship to Clinical Outcome

Autor: Cherrington, J. M., Fuller, M. D., Lamy, P. D., Miner, R., Lalezari, J. P., Nuessle, S., Drew, W. L.

Publikováno v: The Journal of Infectious Diseases, 1998 Dec 01. 178(6), 1821-1825.

Externí odkaz: https://www.jstor.org/stable/30111494

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Week 48 safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants (BRIGHTE study)

Autor: Aberg, J, Molina, J, Kozal, M, Cahn, P, Lalezari, J, Thompson, M, Diaz, R, Castagna, A, Pialoux, G, Gummel, M, Pierce, A, Ackerman, P, Llamoso, C, Lataillade, M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::28e4c868b2628c0c61f60c00e7aa4e5a

(S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue

Autor: Lalezari, J. P., Drew, W. L., Glutzer, E., James, C., Miner, D., Flaherty, J., Fisher, P. E., Cundy, K., Hannigan, J., Martin, J. C., Jaffe, H. S.

Publikováno v: The Journal of Infectious Diseases, 1995 Apr 01. 171(4), 788-796.

Externí odkaz: https://www.jstor.org/stable/30132163

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

Autor: Lalezari, S, Chou, AP, Tran, A, Solis, OE, Khanlou, N, Chen, W, Li, S, Carrillo, JA, Chowdhury, R, Selfridge, J, Sanchez, DE, Wilson, RW, Zurayk, M, Lalezari, J, Lou, JJ, Ormiston, L, Ancheta, K, Hanna, R, Miller, P, Piccioni, D, Ellingson, BM, Buchanan, C, Mischel, PS, Nghiemphu, PL, Green, R, Wang, HJ, Pope, WB, Liau, LM, Elashoff, RM, Cloughesy, TF, Yong, WH, Lai, A

Publikováno v: Lalezari, S; Chou, AP; Tran, A; Solis, OE; Khanlou, N; Chen, W; et al.(2013). Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro-Oncology, 15(3), 370-381. doi: 10.1093/neuonc/nos308. UCLA: Retrieved from: http://www.escholarship.org/uc/item/5fc2v4np

BackgroundPromoter methylation of the DNA repair gene, O-6-methylguanine- DNA methyltransferase (MGMT), is associated with improved treatment outcome for newly diagnosed glioblastoma (GBM) treated with standard chemoradiation. To determine the progno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::de013e6497d0abc7e6feddeae9da6761
http://www.escholarship.org/uc/item/5fc2v4np